Tamoxifen and pregnancy: an absolute contraindication?
Schuurman, T. N., Witteveen, P. O., van der Wall, E., Passier, J. L. M., Huitema, A. D. R., Amant, F., Lok, C. A. R.
Published in Breast cancer research and treatment (01.05.2019)
Published in Breast cancer research and treatment (01.05.2019)
Get full text
Journal Article
Prospective practice survey of management of cetuximab-related skin reactions
Lugtenberg, R. T., Boers-Doets, C. B., Witteveen, P. O., van Herpen, C. M. L., Wymenga, A. N. M., de Groot, J. W. B., Hoeben, A., del Grande, C., van Doorn, B., Koldenhof, J. J., Driessen, C. M. L., Gelderblom, H.
Published in Supportive care in cancer (01.07.2021)
Published in Supportive care in cancer (01.07.2021)
Get full text
Journal Article
Clinical evaluation of AZD1152, an i.v. inhibitor of Aurora B kinase, in patients with solid malignant tumors
Boss, D.S., Witteveen, P.O., van der Sar, J., Lolkema, M.P., Voest, E.E., Stockman, P.K., Ataman, O., Wilson, D., Das, S., Schellens, J.H.
Published in Annals of oncology (01.02.2011)
Published in Annals of oncology (01.02.2011)
Get full text
Journal Article
Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer—Gynaecological Cancer Group)
Witteveen, P.O., van der Velden, J., Vergote, I., Guerra, C., Scarabeli, C., Coens, C., Demonty, G., Reed, N.
Published in Annals of oncology (01.09.2009)
Published in Annals of oncology (01.09.2009)
Get full text
Journal Article
Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment
Devriese, L. A., Witteveen, P. O., Marchetti, S., Mergui-Roelvink, M., Reyderman, L., Wanders, J., Jenner, A., Edwards, G., Beijnen, J. H., Voest, E. E., Schellens, J. H. M.
Published in Cancer chemotherapy and pharmacology (01.12.2012)
Published in Cancer chemotherapy and pharmacology (01.12.2012)
Get full text
Journal Article
Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors
Stuurman, F. E., Voest, E. E., Awada, A., Witteveen, P. O., Bergeland, T., Hals, P.-A., Rasch, W., Schellens, J. H. M., Hendlisz, A.
Published in Investigational new drugs (01.08.2013)
Published in Investigational new drugs (01.08.2013)
Get full text
Journal Article
Patient‐reported symptoms and stepwise symptom management in patients on epidermal growth factor inhibitors: A retrospective, descriptive cohort study
Koldenhof, J.J., Langenberg, M.H.G., Witteveen, P.O., Teunissen, S.C.C.M.
Published in European journal of cancer care (01.03.2018)
Published in European journal of cancer care (01.03.2018)
Get full text
Journal Article
Phase I evaluation of telatinib, a VEGF receptor tyrosine kinase inhibitor, in combination with bevacizumab in subjects with advanced solid tumors
Langenberg, M.H.G., Witteveen, P.O., Roodhart, J., Lolkema, M.P., Verheul, H.M.W., Mergui-Roelvink, M., Brendel, E., Krätzschmar, J., Loembé, B., Nol-Boekel, A., Christensen, O., Schellens, J.H.M., Voest, E.E.
Published in Annals of oncology (01.11.2011)
Published in Annals of oncology (01.11.2011)
Get full text
Journal Article
Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer
Timmermans, M., van der Aa, M.A., Lalisang, R.I., Witteveen, P.O., Van de Vijver, K.K., Kruitwagen, R.F., Sonke, G.S.
Published in Gynecologic oncology (01.09.2018)
Published in Gynecologic oncology (01.09.2018)
Get full text
Journal Article
Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)
Post, C.C.B., Westermann, A.M., Boere, I.A., Witteveen, P.O., Ottevanger, P.B., Sonke, G.S., Lalisang, R.I., Putter, H., Meershoek-Klein Kranenbarg, E., Braak, J.P.B.M., Creutzberg, C.L., Bosse, T., Kroep, J.R.
Published in Gynecologic oncology (01.05.2022)
Published in Gynecologic oncology (01.05.2022)
Get full text
Journal Article
Phase I/II study of single agent MCLA-128, a full length IgG1 bispecific antibody targeting the HER3 pathway: Overall safety at the recommended phase II dose (R2PD) and preliminary activity in HER2+ metastatic gastric/gastroesophageal junction cancer (GC/GEJ)
Alsina, M., Varga, A., Amatu, A., Schellens, J.H.M., Witteveen, P.O., Boni, V., Moreno, V., Bol, K., Lourbakos, A., Magin Ferrer, M., Wasserman, E.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors
Kuppens, I E L M, Witteveen, P O, Schot, M, Schuessler, V M, Daehling, A, Beijnen, J H, Voest, E E, Schellens, J H M
Published in Investigational new drugs (01.06.2007)
Published in Investigational new drugs (01.06.2007)
Get full text
Journal Article
Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours
Kerklaan, B Milojkovic, Lolkema, M P J, Devriese, L A, Voest, E E, Nol-Boekel, A, Mergui-Roelvink, M, Langenberg, M, Mykulowycz, K, Stoebenau, J, Lane, S, Legenne, P, Wissel, P, Smith, D A, Giantonio, B J, Schellens, J H M, Witteveen, P O
Published in British journal of cancer (01.09.2015)
Published in British journal of cancer (01.09.2015)
Get full text
Journal Article
Intraperitoneal treatment for advanced ovarian cancer, the Dutch experience. What did we learn?
Rietveld, M J A, van der Velden, J, Westermann, A M, van Driel, W J, Sonke, G S, Witteveen, P O, Ploos van Amstel, F K, Massuger, L F A G, Ottevanger, P B
Published in Netherlands journal of medicine (01.12.2020)
Get full text
Published in Netherlands journal of medicine (01.12.2020)
Journal Article
A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors
Milojkovic Kerklaan, B., Slater, S., Flynn, M., Greystoke, A., Witteveen, P. O., Megui-Roelvink, M., de Vos, F., Dean, E., Reyderman, L., Ottesen, L., Ranson, M., Lolkema, M. P. J., Plummer, R., Kristeleit, R., Evans, T. R. J., Schellens, J. H. M.
Published in Investigational new drugs (01.06.2016)
Published in Investigational new drugs (01.06.2016)
Get full text
Journal Article
Specialized Care and Survival of Ovarian Cancer Patients in The Netherlands: Nationwide Cohort Study
Vernooij, Flora, Heintz, A. Peter M., Witteveen, Petronella O., van der Heiden-van der Loo, Margriet, Coebergh, Jan-Willem, van der Graaf, Yolanda
Published in JNCI : Journal of the National Cancer Institute (19.03.2008)
Published in JNCI : Journal of the National Cancer Institute (19.03.2008)
Get full text
Journal Article